Latest filing published 02 Jan 2025 for enVVeno Medical Corp, €9,888.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Robert Gray: trading record in brief
Robert Gray, listed as board member, appears in our data through filings on enVVeno Medical Corp shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 18 July 2020 and the latest from 31 December 2024.
Purchases make up the whole of the open-market record (2 purchases, €20k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant and 2 option exercises. So far in 2025, the count stands at 1 purchase and no sales.
The latest filing, published on 2 January 2025, reports an open-market purchase of €9,888 in enVVeno Medical Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Gray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500 shares@ US$2.94100.0% of flowCommon StockSEC:0001493152-25-000058:0Canonical exit: 31 Mar 2025 (T+90)
- 1,041 sharesCommon StockSEC:0001493152-22-026071:0
- 1,042 sharesCommon StockSEC:0001493152-21-022862:0
- 2,000 shares@ US$6.25100.0% of flowCommon StockSEC:0001493152-21-014906:0Canonical exit: 14 Sept 2021 (T+90)
4 of 4 declarations